Current price is more than the intrinsic value

Intrinsic Value

Stock has been generating better return on equity than bank FD

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Lupin, Divis Labs Fall To 52-week Low; How Have They Fared Against Nifty Pharma?

The company has earmarked an aggressive capex of around Rs 2,000 crore over next two years in order to take a chunk of around $20 billion opportunity of APIs going off-patent over FY23-25.

Divis Labs sheds 14% in two days, hits 52-week low post Q4 results

Divis Labs said that the record date for the purpose of the payment of dividend will be informed in due course

Pharma stock recommends dividend of ₹30. Details here

Weak performance likely on a sequential basis

Q4FY22 Preview: Divis Laboratories: Revenues seen at Rs23,432 million, PAT at Rs7,098 million

Share Market से जुड़ी हर छोटी या बड़ी खबर, चाहे हो Nifty में आए नए हाई या फिर, हो आपके के लिए स्टॉक्स पर राय, बिजनेस न्यूज हो या पॉलिटिकल न्यूज, कोरोनावायरस की न्यूज हो या फिर इलेक्शन, देखें CNBC Awaaz और रहे हर खबर से updated.


#LIC #LICIPO #CNBCAwaaz #CNBCAwaazLive #BusinessNewsLive #AajKaTajaKhabar #StockMarketLive #ShareMarketLive


CNBC Awaaz is India’s number one business channel and an undisputed leader in business news and information for the last ten years. Our channel aims to educate, inform and inspire consumers to go beyond limitations, with practical tips on personal finance, investing, technology, consumer goods and capital markets. Policymakers and business owners alike have grown to trust CNBC Awaaz as the most reliable source with its eye on India’s business climate. Our programming gives consumers a platform to make decisions with confidence.

Subscribe to the CNBC Awaaz YouTube channel here: https://tinyurl.com/y5rsvesk

Follow CNBC Awaaz on Twitter: https://twitter.com/CNBC_Awaaz
Like us on our CNBC Awaaz Facebook page: https://www.facebook.com/cnbcawaaz
Website: https://bit.ly/3230WJW

Divis Lab Share News: जानें निवेश को लेकर क्या है Expert की राय | Kamai Ka Adda | CNBC Awaaz

“ Sun Pharma could be one of the best performing stocks followed by Divis. I think these two remain the top ideas on pharma. Among defence stocks, BEL remains the top pick followed by HAL and BDL. In the largecap space, BEL has more potential from current levels and is followed by HAL and BDL.”

5 stocks to bet on in pharma and defence: Rahul Shah

CLOSING BELL: Hindalco tumbled 5 per cent, followed by Divis Labs, Apollo Hospitals, RIL, Wipro, Eicher Motors, Dr Reddy’s Labs, and Cipla

RIL, HDFC Bk drag Sensex 115pts, Nifty holds 17,450; indices up 19% in FY22

Alkem Lab, Pfizer, and Divis Lab were also among the top gainers. Cipla, Granules India, and Lupin were trading in the red.

Nifty Pharma stocks continue to rally; Dr. Reddy’s, Strides Pharma emerge top gainers

Divis Laboratories Ltd is quoting at Rs 4392.45, up 1.22% on the day as on 12:49 IST on the NSE. The stock is up 28.77% in last one year as compared to a 12.3% spurt in NIFTY and a 11.19% spurt in the Nifty Pharma.

Divis Laboratories Ltd up for fifth session

Sharekhan is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 5620 in its research report dated March 09, 2022.

Buy Divis Laboratories: target of Rs 5620: Sharekhan

Closing Bell: Hindalco, UPL, Sun Pharma, Adani Ports, Divis Labs, and TCS were the top drags, down up to 3.45 per cent

Sensex falls 149 pts; SmallCap index sheds 2% amid tepid global cues

Divi's Laboratories Limited is engaged in manufacturing and sale of active pharmaceutical ingredients (APIs) and Intermediates. Its products include Generic APIs, Intermediates, Peptide Building Blocks and Carotenoids.

Divi's Laboratories Ltd

Divi's Laboratories Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Lupin, Divis Labs Fall To 52-week Low; How Have They Fared Against Nifty Pharma?

Divis Labs sheds 14% in two days, hits 52-week low post Q4 results

Pharma stock recommends dividend of ₹30. Details here

Q4FY22 Preview: Divis Laboratories: Revenues seen at Rs23,432 million, PAT at Rs7,098 million

News Video

Divis Lab Share News: जानें निवेश को लेकर क्या है Expert की राय | Kamai Ka Adda | CNBC Awaaz

5 stocks to bet on in pharma and defence: Rahul Shah

RIL, HDFC Bk drag Sensex 115pts, Nifty holds 17,450; indices up 19% in FY22

Nifty Pharma stocks continue to rally; Dr. Reddy’s, Strides Pharma emerge top gainers

Divis Laboratories Ltd up for fifth session

Buy Divis Laboratories: target of Rs 5620: Sharekhan

Divi's Laboratories Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Lupin, Divis Labs Fall To 52-week Low; How Have They Fared Against Nifty Pharma?

Divis Labs sheds 14% in two days, hits 52-week low post Q4 results

Pharma stock recommends dividend of ₹30. Details here

Q4FY22 Preview: Divis Laboratories: Revenues seen at Rs23,432 million, PAT at Rs7,098 million

News Video

Divis Lab Share News: जानें निवेश को लेकर क्या है Expert की राय | Kamai Ka Adda | CNBC Awaaz

5 stocks to bet on in pharma and defence: Rahul Shah

RIL, HDFC Bk drag Sensex 115pts, Nifty holds 17,450; indices up 19% in FY22

Nifty Pharma stocks continue to rally; Dr. Reddy’s, Strides Pharma emerge top gainers

Divis Laboratories Ltd up for fifth session

Buy Divis Laboratories: target of Rs 5620: Sharekhan

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock